Literature DB >> 18326058

Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study.

R Elkaïm1, M Dahan, L Kocgozlu, S Werner, D Kanter, J G Kretz, H Tenenbaum.   

Abstract

BACKGROUND AND
OBJECTIVE: Previous studies have reported different periodontal bacteria in atherosclerotic lesions, but their involvement in plaque formation remains unclear. The aim of the present study was to investigate the presence of 20 periodontal bacteria in atherosclerotic samples and healthy blood vessels (used as controls) and to clarify their relationship in regard to clinical and bacteriological periodontal status.
MATERIAL AND METHODS: The day before vascular surgery the patients had a thorough periodontal examination and bacteriological samples were taken from periodontally diseased sites. Atheromatous plaques, internal mammary arteries and saphenous veins were harvested during surgery. A DNA-DNA hybridization procedure was used to screen periodontal and vascular samples for the 20 selected bacterial species.
RESULTS: Periodontal samples from the severe periodontitis group were found to have a higher prevalence and biomass of bacterial species than the moderate periodontitis group. In vessel samples, the prevalence of the same 20 bacterial species analyzed together was similar in the two groups, except for saphenous veins.
CONCLUSION: The presence of periodontal pathogens in atherosclerotic plaques and in apparently healthy vessels appeared to reflect a higher level of bacteremia rather than infection of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326058     DOI: 10.1111/j.1600-0765.2007.01018.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  25 in total

1.  Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.

Authors:  Haihua Zhu; Xiaolong Lin; Pei Zheng; Hui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.

Authors:  Pei-Feng Liu; Wenyuan Shi; Wenhong Zhu; Jeffery W Smith; Shie-Liang Hsieh; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

Review 3.  Mechanisms involved in the association between periodontal diseases and cardiovascular disease.

Authors:  R Teles; C-Y Wang
Journal:  Oral Dis       Date:  2011-01-11       Impact factor: 3.511

4.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

Review 5.  Fusobacterium nucleatum: a commensal-turned pathogen.

Authors:  Yiping W Han
Journal:  Curr Opin Microbiol       Date:  2015-01-08       Impact factor: 7.934

6.  Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling.

Authors:  Shailendra P Singh; Olivier Huck; Nader G Abraham; Salomon Amar
Journal:  J Immunol       Date:  2018-07-23       Impact factor: 5.422

7.  Possible translocation of periodontal pathogens into the lymph nodes draining the oral cavity.

Authors:  G Amodini Rajakaruna; Makoto Umeda; Keisuke Uchida; Asuka Furukawa; Bae Yuan; Yoshimi Suzuki; Ebe Noriko; Yuichi Izumi; Yoshinobu Eishi
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

Review 8.  Biogenesis and function of Porphyromonas gingivalis outer membrane vesicles.

Authors:  H Xie
Journal:  Future Microbiol       Date:  2015-09-07       Impact factor: 3.165

9.  A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis.

Authors:  Pei-Feng Liu; Susan Kinder Haake; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2009-01-20       Impact factor: 3.641

10.  Implication of Toll/IL-1 receptor domain containing adapters in Porphyromonas gingivalis-induced inflammation.

Authors:  Isaac M Bugueno; Nadia Benkirane-Jessel; Olivier Huck
Journal:  Innate Immun       Date:  2021-05-21       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.